Insider Trades
Common-stock transactions that officers, directors and 10% owners of healthcare companies report to the SEC on Form 4, from 2006 to today, newest first.
Insider filings are public records and are not a recommendation.
Results
25+ transactions, newest first
| Date | Insider | Relationship | Company | Transaction | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Ernest Opella Finley | Director | Privia Health Group, Inc.PRVA | OtherA · Grant or award from the company | 6,350 | $0.00 | $0 | 6,350Direct | Form 4 filed 3 Sep 2026, on sec.gov (opens in a new tab)Filed 3 Sep 2026 | |
| Mountcastle David | EVP & Chief Financial Officer | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 21,275 | $27.67 | $588,679.25 | 164,853Direct | Form 4 filed 13 Jul 2026, on sec.gov (opens in a new tab)Filed 13 Jul 2026 | |
| Mountcastle David | EVP & Chief Financial Officer | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 600 | $27.57 | $16,542 | 186,128Direct | Form 4 filed 9 Jul 2026, on sec.gov (opens in a new tab)Filed 9 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 53,722 | $27.24 | $1,463,387.28 | 68,188Direct | Form 4 filed 7 Jul 2026, on sec.gov (opens in a new tab)Filed 7 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | OtherM · Option or derivative exercised or converted | 53,722 | $2.00 | $107,444 | 130,373Direct | Form 4 filed 7 Jul 2026, on sec.gov (opens in a new tab)Filed 7 Jul 2026 | |
| Mountcastle David | EVP & Chief Financial Officer | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 24,734 | $27.50 | $680,185 | 186,728Direct | Form 4 filed 7 Jul 2026, on sec.gov (opens in a new tab)Filed 7 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 59,037 | $27.33 | $1,613,481.21 | 76,651Direct | Form 4 filed 7 Jul 2026, on sec.gov (opens in a new tab)Filed 7 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | OtherM · Option or derivative exercised or converted | 59,037 | $2.00 | $118,074 | 135,688Direct | Form 4 filed 7 Jul 2026, on sec.gov (opens in a new tab)Filed 7 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 37,041 | $26.93 | $997,514.13 | 76,651Direct | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 45,634 | $26.52 | $1,210,213.68 | 113,692Direct | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | OtherM · Option or derivative exercised or converted | 82,675 | $2.00 | $165,350 | 159,326Direct | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 52,823 | $25.72 | $1,358,607.56 | 76,651Direct | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | OtherM · Option or derivative exercised or converted | 52,823 | $2.00 | $105,646 | 129,474Direct | Form 4 filed 2 Jul 2026, on sec.gov (opens in a new tab)Filed 2 Jul 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 63,212 | $25.33 | $1,601,159.96 | 76,651Direct | Form 4 filed 30 Jun 2026, on sec.gov (opens in a new tab)Filed 30 Jun 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | OtherM · Option or derivative exercised or converted | 63,212 | $2.00 | $126,424 | 139,863Direct | Form 4 filed 30 Jun 2026, on sec.gov (opens in a new tab)Filed 30 Jun 2026 | |
| Mountcastle David | EVP & Chief Financial Officer | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 17,196 | $25.18 | $432,995.28 | 211,462Direct | Form 4 filed 30 Jun 2026, on sec.gov (opens in a new tab)Filed 30 Jun 2026 | |
| Mountcastle David | EVP & Chief Financial Officer | Privia Health Group, Inc.PRVA | OtherM · Option or derivative exercised or converted | 17,196 | $2.00 | $34,392 | 228,658Direct | Form 4 filed 30 Jun 2026, on sec.gov (opens in a new tab)Filed 30 Jun 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | SellS · Open-market or private sale | 88,110 | $25.33 | $2,231,826.30 | 76,651Direct | Form 4 filed 30 Jun 2026, on sec.gov (opens in a new tab)Filed 30 Jun 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | OtherM · Option or derivative exercised or converted | 88,110 | $2.00 | $176,220 | 164,761Direct | Form 4 filed 30 Jun 2026, on sec.gov (opens in a new tab)Filed 30 Jun 2026 | |
| COCOZZA NANCY G | Director | Privia Health Group, Inc.PRVA | OtherA · Grant or award from the company | 8,463 | $0.00 | $0 | 42,814Direct | Form 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026 | |
| BERBERIAN LANCE | Director | Privia Health Group, Inc.PRVA | OtherA · Grant or award from the company | 8,463 | $0.00 | $0 | 16,131Direct | Form 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026 | |
| KING DAVID P | Director | Privia Health Group, Inc.PRVA | OtherA · Grant or award from the company | 8,463 | $0.00 | $0 | 50,775Direct | Form 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026 | |
| McCarthy Thomas A | Director | Privia Health Group, Inc.PRVA | OtherA · Grant or award from the company | 8,463 | $0.00 | $0 | 27,983Direct | Form 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026 | |
| Ryu Jaewon | Director | Privia Health Group, Inc.PRVA | OtherA · Grant or award from the company | 8,463 | $0.00 | $0 | 47,110Direct | Form 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026 | |
| Morris Matthew Shawn | Director | Privia Health Group, Inc.PRVA | OtherA · Grant or award from the company | 8,463 | $0.00 | $0 | 76,651Direct | Form 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026 |
Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.